We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
Cap. Flow
+$1.21B
Cap. Flow %
2.54%
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$22.7M
2
CNC icon
Centene
CNC
+$20M
3
IR icon
Ingersoll Rand
IR
+$18.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.8M
5
DLR icon
Digital Realty Trust
DLR
+$15.4M

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Healthcare 14.79%
3 Financials 13.95%
4 Consumer Discretionary 9.78%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBX
2551
DELISTED
Unity Biotechnology
UBX
$213K ﹤0.01%
3,664
+10
+0.3% +$630
MNRL
2552
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$213K ﹤0.01%
25,772
+8,550
+50% +$129K
RBNC
2553
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$213K ﹤0.01%
18,915
+3,500
+23% +$67.2K
TSBK icon
2554
Timberland Bancorp
TSBK
$351M
$212K ﹤0.01%
11,577
TREC
2555
DELISTED
Trecora Resources
TREC
$212K ﹤0.01%
35,590
+1,900
+6% +$12.1K
ESXB
2556
DELISTED
Community Bankers Trust Corporation
ESXB
$212K ﹤0.01%
43,735
+11,000
+34% +$87.4K
ARCC icon
2557
Ares Capital
ARCC
$14.4B
$211K ﹤0.01%
19,563
+40
+0.2% +$675
LAB icon
2558
Standard BioTools
LAB
$314M
$211K ﹤0.01%
83,165
-656
-0.8% -$2.15K
GCAP
2559
DELISTED
Gain Capital Holdings, Inc.
GCAP
$211K ﹤0.01%
37,869
+100
+0.3% +$447
BEAM icon
2560
Beam Therapeutics
BEAM
$2.84B
$210K ﹤0.01%
+11,693
New +$254K
FSBW icon
2561
FS Bancorp
FSBW
$320M
$210K ﹤0.01%
11,650
TIPT icon
2562
Tiptree Inc
TIPT
$675M
$210K ﹤0.01%
40,225
AMRS
2563
DELISTED
Amyris Inc.
AMRS
$210K ﹤0.01%
82,125
+13,071
+19% +$38.1K
GLOG
2564
DELISTED
GASLOG LTD
GLOG
$210K ﹤0.01%
57,998
+530
+0.9% +$3.23K
CHK
2565
DELISTED
Chesapeake Energy Corporation
CHK
$210K ﹤0.01%
6,057
-7,881
-57% -$692K
CULP icon
2566
Culp Inc
CULP
$44.1M
$209K ﹤0.01%
28,398
+7,180
+34% +$77.6K
DSGR icon
2567
Distribution Solutions Group
DSGR
$1.61B
$209K ﹤0.01%
15,614
-50
-0.3% -$1.09K
ALV icon
2568
Autoliv
ALV
$9B
$208K ﹤0.01%
4,524
+102
+2% +$7K
SCTL
2569
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$208K ﹤0.01%
25,479
+244
+1% +$3.39K
UBFO
2570
DELISTED
United Security Bancshares
UBFO
$207K ﹤0.01%
32,271
+8,000
+33% +$71.9K
AOSL icon
2571
Alpha and Omega Semiconductor
AOSL
$1.08B
$204K ﹤0.01%
31,853
+540
+2% +$5.87K
IHC
2572
DELISTED
Independence Holding Company
IHC
$204K ﹤0.01%
7,984
CHMI
2573
Cherry Hill Mortgage Investment Corp
CHMI
$88.5M
$203K ﹤0.01%
32,733
+6,360
+24% +$83.4K
ASTH icon
2574
Astrana Health
ASTH
$1.77B
$203K ﹤0.01%
15,719
-301
-2% -$4.91K
RPT
2575
Rithm Property Trust
RPT
$93.7M
$203K ﹤0.01%
5,326
+923
+21% +$70.2K

Similar funds

RhumbLine Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
  • RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
  • RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
  • RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
  • RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
  • RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
  • RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.